Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system.
Morrisville, NC (PRWEB) February 1, 2010 -- Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system. PASS Rx scientifically verifies, within a closed pill vial, the majority of the oral solid medications to improve the dispense accuracy in pharmacies. PASS Rx is the most reliable solution to allow pharmacies to protect themselves and their patients.
According to a 2006 report from the Institute of Medicine, at least 1.5 million Americans are injured by medication errors every year, many due to the wrong drug or strength being dispensed. Another study states that about four drug or strength errors occur per day in a pharmacy with a daily volume of 250 prescriptions. Manual verification can be largely subjective; Centice can help.
The new enhancements in Version 3.0 include an increased database size to over two thousand unique medications, which equates to more than 20,000 NDCs. In addition, PASS Rx can now be used to perform accuracy scans for barcode-based verification of non-vial dispensed drugs. Combined, these enhancements enable PASS Rx to cover nearly 100% of the workflow in retail and hospital outpatient pharmacies.
After multiple customer focus groups were conducted, the new user interface was also improved to provide the pharmacist or technician with easy to understand results on the display. The user interface continues to provide Medi-Span® drug images and descriptions for the added value of visual verification.
Centice Corporation provides its customers with storage and reporting capabilities to enhance quality control in the pharmacy. Anything scanned and/or analyzed through the PASS Rx system is captured for future reporting on how many scripts were filled, how many were run through PASS Rx and how many errors have been caught.
Periodic updates are provided remotely so that Centice may provide its customers with the most up-to-date information as drugs are added or removed from the library and for faster customer service.
”We are thrilled to offer our pharmacy customers an improved solution that will assist them in increasing their quality and efficiency, ultimately allowing them to do what they do best, spend more time consulting with their patients,” said Scott Albert, Chairman of the Board and Chief Executive Officer of Centice.
About Centice Corporation
Centice, founded in 2004 and headquartered in Morrisville, NC, is commercializing patented and patent-pending computational sensor and machine vision technology. The PASS Rx® pharmaceutical authentication sensor system improves the verification process for dispensed medications, thereby improving quality and optimizing workflow in the pharmacy. The company has received venture capital investments from The Aurora Funds, Inc., Novak Biddle Venture Partners, S-Group Direct Investments Ltd, Innovation Ventures LP, Fulcrum Financial Group, L.P. and other private investors. More information on Centice can be found at www.centice.com.
# # #
Read the full story at http://www.prweb.com/releases/2010/02/prweb3537194.htm.
Copyright©2010 Vocus, Inc.
All rights reserved